SCHEMBL25688271

SCHEMBL25688271

OC(COCOCC(O)COc1ccccc1)COc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.57
CYP2D6 P10635 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ADRB2 P07550 1/20 0.54
ADRB1 P08588 1/20 0.54
ADRB3 P13945 1/20 0.54
KDM4E B2RXH2 1/20 0.53
MAPT P10636 2/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TSHR P16473 1/20 0.51
HIF1A Q16665 1/20 0.51
RECQL P46063 1/20 0.51
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11400908 0.92 LMNA (0.61) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL25688257 0.91 LMNA (0.53) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL267463 0.89 LMNA (0.68) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL11959217 0.85 LMNA (0.58) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL5087030 0.85 LMNA (0.53) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL23135358 0.85 LMNA (0.53) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL16928532 0.83 LMNA (0.72) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL12787423 0.83 LMNA (0.56) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL10710354 0.83 RECQL (0.57) LMNACYP2D6L3MBTL1ADRB2ADRB1
SCHEMBL9662754 0.83 CA1 (0.64) LMNACYP2D6L3MBTL1ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760711-B2 Epoxy compound, composition, cured product and laminate DIC CORPORATION (JP) 2023-09-19 US disclosed
US-11685807-B2 Resin composition, cured product, laminate, and electronic member DIC CORPORATION (JP) 2023-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760711-B2 Epoxy compound, composition, cured product and laminate ARL1, DOT1L, RFT1 LMNA 82/4885CYP2D6 2805/4885L3MBTL1 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.